25 - First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
| Autor: | Massard, C., Azaro, A., Soria, J.C., Lassen, U., Le Tourneau, C., Smith, C., Ohnmacht, U., Oakley, G., Patel, B.K.R., Yuen, E.S.M., Benhadji, K.A., Rodon, J. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S15-S15 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect